Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTION-III late preterm antenatal corticosteroids trial
ISRCTN11434567Phase 3Completed
- Sponsor
- World Health Organization
- Start
- Jul 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in preterm birth comparing Dexamethasone phosphate, Betamethasone phosphate and Placebo (3 arms). Primary endpoint: Primary composite neonatal outcome. Started Jul 2022; status: completed.
02
Drugs
dexamethasone sodium phosphatebetamethasone sodium
03
Conditions
preterm birth
Beyond the preview
Go deeper on ISRCTN11434567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN11434567.